Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.4 GBX | 0.00% | 0.00% | -20.00% |
Apr. 30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
Apr. 15 | Fusion Antibodies inks commercial contract for OptiPhage library | AN |
Sales 2024 * | 1.15M 1.44M | Sales 2025 * | - | Capitalization | 3.24M 4.06M |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.25M | Net income 2025 * | - | EV / Sales 2024 * | 2.82 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.21
x | P/E ratio 2025 * |
-
| Employees | 48 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.63% |
1 day | +1.76% | ||
1 week | +3.28% | ||
Current month | +7.29% | ||
1 month | -17.62% | ||
3 months | -18.59% | ||
6 months | -3.89% | ||
Current year | -18.59% |
Managers | Title | Age | Since |
---|---|---|---|
Adrian Kinkaid
CEO | Chief Executive Officer | 57 | 22-08-14 |
Stephen Smyth
DFI | Director of Finance/CFO | 49 | 23-08-23 |
Simon Douglas
CHM | Chairman | 65 | 05-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Colin Walsh
BRD | Director/Board Member | 68 | 06-12-31 |
Simon Douglas
CHM | Chairman | 65 | 05-12-31 |
Richard Buick
CTO | Chief Tech/Sci/R&D Officer | 47 | 01-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 3.4 | 0.00% | 455 210 |
24-05-09 | 3.4 | 0.00% | 189,748 |
24-05-08 | 3.4 | 0.00% | 1,253,797 |
24-05-07 | 3.4 | +1.49% | 437,279 |
24-05-03 | 3.35 | -1.47% | 869,509 |
Delayed Quote London S.E., May 10, 2024 at 07:06 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.59% | 4.06M | |
+23.37% | 47.02B | |
+50.07% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- FAB Stock